Jim Simons started to build up the position in AgeX Therapeutics in Q4 2020 and continued to invest until Q1 2021. Since then they sold 15k shares. The investor completely sold their stake between Q2 2021 and Q3 2021.
Avg closing price
Price range
Sold -3.41k shares
Q3 2021
Avg closing price
$1.19
Price range
$0.93
-
$1.54
Sold 77.3% shares (-11.6k shares)
Q2 2021
Avg closing price
$1.43
Price range
$1.14
-
$1.77
Increased shares by 212.7% (+10.2k shares)
Q1 2021